AC137056.1 | Uncharacterized protein; cDNA FLJ34659 fis, clone KIDNE2018863 | Predicted secreted proteins
| | | | | Group enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
ACOT6 | Acyl-CoA thioesterase 6 | | | | | | Group enriched |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
AL138847.1 | CDNA FLJ26506 fis, clone KDN07105; Uncharacterized protein | Predicted secreted proteins
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | | | | Group enriched |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Group enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CES5A | Carboxylesterase 5A | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLDN14 | Claudin 14 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CYP4A11 | Cytochrome P450, family 4, subfamily A, polypeptide 11 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
CYP4A22 | Cytochrome P450, family 4, subfamily A, polypeptide 22 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Transcription factors
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLYAT | Glycine-N-acyltransferase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
HAO2 | Hydroxyacid oxidase 2 (long chain) | Enzymes
| | | | | Group enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | | | | | Group enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MPPED1 | Metallophosphoesterase domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
MT1B | Metallothionein 1B | | | | | | Group enriched |
PIPOX | Pipecolic acid oxidase | Enzymes Plasma proteins
| | | | | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| | | | | Group enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
RIPPLY1 | Ripply transcriptional repressor 1 | Predicted secreted proteins
| | | | | Group enriched |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A7 | Solute carrier family 22 (organic anion transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |